Skip to main content

Table 4 Association of family history and number of primaries with prevalence of CDKN2A mutations

From: Prevalence and predictors of germline CDKN2A mutations for melanoma cases from Australia, Spain and the United Kingdom

 

Australia

Spain

UK

 

Total

Predictor

No./total cases1

%

OR2(95% CI)

No./total cases

%

OR (95% CI)

No./total cases

%

OR (95% CI)

%

Multivariate OR3

Family history 4

           

0

7/500

1.4

1.0

13/696

1.9

1.0

20/1470

1.4

1.0

1.5

1.0

1

4/76

5.3

3.9 (1.1, 13.7)

3/35

8.6

4.9 (1.3, 18.2)

4/101

4.0

3.0 (1.0, 8.9)

5.2

3.8 (1.9, 7.5)

2+

3/20

15.0

12.4 (3.0, 52.3)

3/16

18.8

12.1 (3.1, 47.7)

7/15

46.7

63.4 (21.0, 19.8)

25.5

23.2 (11.3, 47.6)

No. of primaries 5

           

1

14/581

2.4

n/a

8/644

1.2

1.0

20/1495

1.4

1.0

1.3

1.0

2

0/14

0

 

6/80

7.5

6.5 (2.2, 19.1)

4/73

5.5

4.3 (1.4, 12.9)

6.5

5.4 (2.5, 11.6)

3+

0/1

0

 

5/23

21.7

22.1 (6.6, 74.2)

7/18

38.9

46.9 (16.5, 133.5)

29.3

32.4 (14.7, 71.2)

  1. 1Number of cases with a pathogenic CDKN2A mutation/the total number of cases.
  2. 2Unadjusted odds ratio.
  3. 3“Family history” analysis ORs adjusted for presence of MPM, age at diagnosis and country; “Number of primaries” analysis adjusted for family history, sex, age at diagnosis and country.
  4. 4Number of first or second degree relatives with melanoma.
  5. 5Number of primary melanomas diagnosed in the case. Few MPMs were observed for the Australian cases due to the study design.